Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · IEX Real-Time Price · USD
1.370
-0.180 (-11.61%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Chromocell Therapeutics Statistics

Total Valuation

CHRO has a market cap or net worth of $7.90 million. The enterprise value is $4.13 million.

Market Cap 7.90M
Enterprise Value 4.13M

Important Dates

The next estimated earnings date is Tuesday, August 20, 2024, before market open.

Earnings Date Aug 20, 2024
Ex-Dividend Date n/a

Share Statistics

CHRO has 5.77 million shares outstanding. The number of shares has increased by 322.19% in one year.

Shares Outstanding 5.77M
Shares Change (YoY) +322.19%
Shares Change (QoQ) +267.48%
Owned by Insiders (%) 72.78%
Owned by Institutions (%) 5.42%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.99
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.39, with zero debt.

Current Ratio 1.39
Quick Ratio 1.31
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.20

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -848.30%
Return on Capital (ROIC) -697.42%
Revenue Per Employee n/a
Profits Per Employee -$2.24M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.62
200-Day Moving Average n/a
Relative Strength Index (RSI) 44.31
Average Volume (20 Days) 15,499

Short Selling Information

The latest short interest is 2,637, so 0.05% of the outstanding shares have been sold short.

Short Interest 2,637
Short Previous Month 111
Short % of Shares Out 0.05%
Short % of Float n/a
Short Ratio (days to cover) 0.09

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -7.88M
Pretax Income -8.98M
Net Income -8.98M
EBITDA -7.88M
EBIT -7.88M
Earnings Per Share (EPS) -$7.03
Full Income Statement

Balance Sheet

The company has $3.77 million in cash and no debt, giving a net cash position of $3.77 million or $0.65 per share.

Cash & Cash Equivalents 3.77M
Total Debt n/a
Net Cash 3.77M
Net Cash Per Share $0.65
Equity / Book Value 1.13M
Book Value Per Share 0.20
Working Capital 1.13M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.80M
Capital Expenditures n/a
Free Cash Flow -2.80M
FCF Per Share -$0.60
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CHRO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -322.19%
Shareholder Yield -322.19%
Earnings Yield -113.61%
FCF Yield -35.43%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2